TOPICS


  • Dissolution
  • IVIVC
  • Formulations and Modified Release Formulations
  • BCS and BDDCS
  • Biowaivers
  • Biosimilars
  • Regulatory Science
  • Pharmacodynamic Endpoints for BE
  • POPPK-PD and Pharmacometrics Applications to  Assess BE
  • Conduct of PBPK and Virtual BE

 

"Anything in between"

  • Factors: Genomic, pharmacogenomic, immunological, chemical, food
  • Delivery: From in vitro transfer embryos to intramuscular, pulmonary, intranasal, and brain drug delivery
  • Virtualization: Machine learning techniques, artificial intelligence, in silico studies
  • Pharmacodynamics: Beyond therapeutic equivalence